Physician profile
Charity Capuras
NPI 1346610201
$1,006.56
in general payments reported to CMS, 2019-2025
13 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $251 · 2023: $157 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.99 |
| Education | $105.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $480.77 | 2021-2025 | Tremfya, Simponi, Remicade |
| Abbvie INC. | $200.85 | 2021-2023 | |
| Amgen INC. | $54.87 | 2022-2025 | Otezla |
| Novartis Pharmaceuticals Corporation | $52.44 | 2021-2025 | |
| Genzyme Corporation | $49.31 | 2021-2025 | |
| Lilly USA, LLC | $39.90 | 2021-2022 | |
| Kaleo, INC. | $30.40 | 2021 | |
| Ucb, INC. | $23.58 | 2023 | Cimzia |
| Incyte Corporation | $19.19 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.49 | 2023 | Sotyktu |
| Pfizer INC. | $15.27 | 2023 | |
| Sun Pharmaceutical Industries INC. | $13.60 | 2023 | Winlevi |
| Biofrontera INC. | $8.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charity Capuras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.